Drugs giant GSK is set to axe up to 350 research and development jobs across the US and UK.
The ongoing overhaul of the division is understood to include cuts to about 50 roles in the group’s main UK R&D hub in Stevenage, Hertfordshire, although the final number of jobs being impacted in Britain and the US is set to be confirmed in the coming months.